Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 347

Results For "NDA"

4483 News Found

Sanofi teams up with McLaren Racing to accelerate industrial excellence
News | April 27, 2022

Sanofi teams up with McLaren Racing to accelerate industrial excellence

Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance


Tembo BV team in India to assist UFlex-Asepto for U-shaped paper straw line
Packaging | April 27, 2022

Tembo BV team in India to assist UFlex-Asepto for U-shaped paper straw line

Tembo and UFlex-Asepto have co-developed 100% renewable and recyclable paper straw solution that will be food grade, moisture-resistant and made from sustainably sourced papers


Lupin appoints Diana Amador-Toro as Senior Vice President, Global Compliance
People | April 27, 2022

Lupin appoints Diana Amador-Toro as Senior Vice President, Global Compliance

Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)


Drugs Controller clears Covaxin, Corbevax and ZyCov-D for kids
News | April 26, 2022

Drugs Controller clears Covaxin, Corbevax and ZyCov-D for kids

The approval by the DCGI comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO)


Malaysia awards three-year contract for Biocon Biologics’ Insugen
Biotech | April 26, 2022

Malaysia awards three-year contract for Biocon Biologics’ Insugen

Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics


Differentiation based on innovation is the way forward: S Aparna
News | April 26, 2022

Differentiation based on innovation is the way forward: S Aparna

Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'


Corbevax gets DCGI nod for Emergency Use in 5-12 years
Drug Approval | April 26, 2022

Corbevax gets DCGI nod for Emergency Use in 5-12 years

The approval comes soon after Corbevax was given the nod for 12-15-year group


DCGI grants Covaxin Emergency Use Approval for children 6-12 years
Drug Approval | April 26, 2022

DCGI grants Covaxin Emergency Use Approval for children 6-12 years

Covaxin was earlier approved for children 12-18 years of age


Global AYUSH meet ends with promise of Rs 9000 cr. in investment
News | April 25, 2022

Global AYUSH meet ends with promise of Rs 9000 cr. in investment

Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal


CanSinoBIO rebrands to reflect commitment to life sciences research
Biotech | April 25, 2022

CanSinoBIO rebrands to reflect commitment to life sciences research

This is the first major brand refresh of CanSinoBIO since its inception in 2009